Financial Reports and Analysis related to IBSRELA XPHOZAH

Ardelyx, Inc. 2024 Financial Report: Growth Amid Challenges

•

Form 10-K

•

2025-02-20

Last updated: 2 months ago

Ardelyx, Inc. 2024 Financial Report: Growth Amid Challenges

Explore Ardelyx, Inc.'s 2024 financial results, highlighting $333.6M in revenue, $39.1M net loss, and key investment risks. A must-read for investors!

Biopharmaceutical Revenue Growth Net Loss Customer Concentration IBSRELA XPHOZAH

Posts With Tag IBSRELA XPHOZAH